Recurring consumables, sequencing-by-synthesis leadership and oncology demand underpin ROI, while reimbursement, AI bioinformatics and Asia-Pacific expansion unlock growth.Dublin, Oct. 01, 2026 (GLOBE ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results